Institut für histologische und zytologische Diagnostik AG Aarau changes ownership

Institut für histologische und zytologische Diagnostik AG Aarau has been sold to Affidea Group
The shareholders of the Institut für histologische und zytologische Diagnostik AG Aarau (IHZD) sold their shares to Affidea Group. With this sale IHZD ensures the long-term sustainability of the institute enabling continued growth and creates new opportunities for their clients and their employees.
The Institut für histologische und zytologische Diagnostik AG Aarau operates two laboratories in Aarau and Zurich offering histopathology, molecular pathology and cytology diagnostics.
Affidea Group is a leading pan-European provider of specialist healthcare services, including cancer care, community-based polyclinics and advanced diagnostic imaging. Affidea Switzerland offers outpatient care, focusing on diagnostic imaging and specialised medicine. Alongside radiology, its areas of expertise include breast medicine, gastroenterology, and managing multi-specialty medical centres.
Gut Corporate Finance supported the shareholders of IZHD as financial advisor in this transaction. The mandate included the entire project management, transaction preparation including market screening, support in preparing the sales documentation, company valuation, organisation of the due diligence, transaction structuring and support in the contract negotiations.